DMAC icon

DiaMedica Therapeutics
DMAC

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$12.33
87% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Matthew Caufield
60% 1-yr DMAC win rate
15 Aug ‘25 2 months ago
Craig-Hallum
Craig-Hallum
Chase Knickerbocker
100% 1-yr DMAC win rate
18 Jul ‘25 3 months ago
Lake Street
Lake Street
Thomas Flaten
100% 1-yr DMAC win rate
18 Jul ‘25 3 months ago